Overview Dividends

(XYL) Xylem - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98419M1009

Pumps, Meters, Controls, Filtration, Analytics

XYL EPS (Earnings per Share)

EPS Growth (3Y CAGR): -57.16%
EPS Trend (3Y Correlation): -19.8%

XYL Revenue

Revenue Growth (3Y CAGR): 20.43%
Revenue Trend (3Y Correlation): 87.7%

Description: XYL Xylem September 29, 2025

Xylem Inc. (NYSE: XYL) designs, manufactures, and services engineered water-related products for utility, industrial, residential, and commercial markets worldwide. The firm operates through four segments: Water Infrastructure; Applied Water; Measurement & Control Solutions; and Water Solutions & Services, leveraging brands such as Flygt, Ionpure, Wallace & Tiernan, Rule, Bell & Gossett, Sensus, and Xylem Vue.

In FY 2023 the company generated approximately $5.6 billion in revenue, a 10 % year-over-year increase, with an adjusted EBITDA margin of roughly 22 %. Recurring revenue from smart-metering and data-analytics services now represents about 15 % of total sales, underscoring the shift toward subscription-based, high-margin offerings.

Key macro drivers include rising global water-infrastructure spending (estimated CAGR ≈ 5 % through 2028), stricter ESG regulations that push utilities toward energy-efficient pumps and digital monitoring, and climate-related resilience investments that boost demand for flood-control and wastewater-treatment solutions. Xylem’s exposure to both capital-intensive infrastructure projects and recurring SaaS-type services gives it a diversified revenue profile.

For a deeper quantitative assessment of XYL’s valuation metrics and scenario analysis, you may find the ValueRay platform useful.

XYL Stock Overview

Market Cap in USD	35,535m
Sub-Industry	Industrial Machinery & Supplies & Components
IPO / Inception	2011-10-13

XYL Stock Ratings

Growth Rating	65.7%
Fundamental	62.5%
Dividend Rating	59.6%
Return 12m vs S&P 500	-2.75%
Analyst Rating	4.05 of 5

XYL Dividends

Dividend Yield 12m	1.04%
Yield on Cost 5y	1.90%
Annual Growth 5y	8.48%
Payout Consistency	100.0%
Payout Ratio	34.1%

XYL Growth Ratios

Growth Correlation 3m	60.3%
Growth Correlation 12m	72.7%
Growth Correlation 5y	60.7%
CAGR 5y	14.04%
CAGR/Max DD 3y (Calmar Ratio)	0.49
CAGR/Mean DD 3y (Pain Ratio)	1.61
Sharpe Ratio 12m	0.52
Alpha	-5.52
Beta	1.128
Volatility	19.28%
Current Volume	2365k
Average Volume 20d	1145.1k
Stop Loss	145.9 (-3.1%)
Signal	0.05

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (938.0m TTM) > 0 and > 6% of Revenue (6% = 523.7m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA -0.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 23.69% (prev 20.71%; Δ 2.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 1.22b > Net Income 938.0m (YES >=105%, WARN >=100%)

Net Debt (954.0m) to EBITDA (1.77b) ratio: 0.54 <= 3.0 (WARN <= 3.5)

Current Ratio 1.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (243.9m) change vs 12m ago 0.13% (target <= -2.0% for YES)

Gross Margin 37.82% (prev 36.85%; Δ 0.97pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 52.97% (prev 53.26%; Δ -0.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 33.22 (EBITDA TTM 1.77b / Interest Expense TTM 36.0m) >= 6 (WARN >= 3)

Altman Z'' 2.47

(A) 0.12 = (Total Current Assets 4.37b - Total Current Liabilities 2.30b) / Total Assets 17.19b

(B) 0.19 = Retained Earnings (Balance) 3.34b / Total Assets 17.19b

(D) 0.53 = Book Value of Equity 3.12b / Total Liabilities 5.88b

Total Rating: 2.47 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 62.54

1. Piotroski 6.0pt = 1.0

2. FCF Yield 2.41% = 1.21

3. FCF Margin 10.09% = 2.52

4. Debt/Equity 0.19 = 2.48

5. Debt/Ebitda 0.54 = 2.28

6. ROIC - WACC (= -2.61)% = -3.26

7. RoE 8.70% = 0.73

8. Rev. Trend 87.69% = 6.58

9. EPS Trend -19.81% = -0.99

What is the price of XYL shares?

As of October 29, 2025, the stock is trading at USD 150.50 with a total of 2,364,986 shares traded.
Over the past week, the price has changed by +2.25%, over one month by +4.55%, over three months by +14.11% and over the past year by +16.44%.

Is Xylem a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Xylem is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 62.54 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XYL is around 147.41 USD . This means that XYL is currently overvalued and has a potential downside of -2.05%.

Is XYL a buy, sell or hold?

Xylem has received a consensus analysts rating of 4.05. Therefore, it is recommended to buy XYL.

Strong Buy: 9
Buy: 5
Hold: 8
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the XYL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	158.7	5.4%
Analysts Target Price	158.7	5.4%
ValueRay Target Price	166	10.3%

XYL Fundamental Data Overview October 24, 2025

Market Cap USD = 35.54b (35.54b USD * 1.0 USD.USD)
P/E Trailing = 38.0182
P/E Forward = 27.7778
P/S = 4.0705
P/B = 3.2753
P/EG = 2.4602
Beta = 1.128
Revenue TTM = 8.73b USD
EBIT TTM = 1.20b USD
EBITDA TTM = 1.77b USD
Long Term Debt = 1.93b USD (from longTermDebt, last quarter)
Short Term Debt = 196.0m USD (from shortTermDebt, last quarter)
Debt = 2.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 954.0m USD (from netDebt column, last quarter)
Enterprise Value = 36.49b USD (35.54b + Debt 2.12b - CCE 1.17b)
Interest Coverage Ratio = 33.22 (Ebit TTM 1.20b / Interest Expense TTM 36.0m)
FCF Yield = 2.41% (FCF TTM 881.0m / Enterprise Value 36.49b)
FCF Margin = 10.09% (FCF TTM 881.0m / Revenue TTM 8.73b)
Net Margin = 10.75% (Net Income TTM 938.0m / Revenue TTM 8.73b)
Gross Margin = 37.82% ((Revenue TTM 8.73b - Cost of Revenue TTM 5.43b) / Revenue TTM)
Gross Margin QoQ = 38.77% (prev 37.12%)
Tobins Q-Ratio = 2.12 (Enterprise Value 36.49b / Total Assets 17.19b)
Interest Expense / Debt = 0.42% (Interest Expense 9.00m / Debt 2.12b)
Taxrate = 25.08% (75.0m / 299.0m)
NOPAT = 896.0m (EBIT 1.20b * (1 - 25.08%))
Current Ratio = 1.90 (Total Current Assets 4.37b / Total Current Liabilities 2.30b)
Debt / Equity = 0.19 (Debt 2.12b / totalStockholderEquity, last quarter 11.07b)
Debt / EBITDA = 0.54 (Net Debt 954.0m / EBITDA 1.77b)
Debt / FCF = 1.08 (Net Debt 954.0m / FCF TTM 881.0m)
Total Stockholder Equity = 10.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.46% (Net Income 938.0m / Total Assets 17.19b)
RoE = 8.70% (Net Income TTM 938.0m / Total Stockholder Equity 10.78b)
RoCE = 9.41% (EBIT 1.20b / Capital Employed (Equity 10.78b + L.T.Debt 1.93b))
RoIC = 7.01% (NOPAT 896.0m / Invested Capital 12.79b)
WACC = 9.61% (E(35.54b)/V(37.66b) * Re(10.17%) + D(2.12b)/V(37.66b) * Rd(0.42%) * (1-Tc(0.25)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.49%
[DCF Debug] Terminal Value 74.84% ; FCFE base≈884.6m ; Y1≈1.09b ; Y5≈1.86b
Fair Price DCF = 90.46 (DCF Value 22.02b / Shares Outstanding 243.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -19.81 | EPS CAGR: -57.16% | SUE: -4.0 | # QB: 0
Revenue Correlation: 87.69 | Revenue CAGR: 20.43% | SUE: 1.85 | # QB: 1

Additional Sources for XYL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle